Q5146 Injection, hercessi, 10 milligrams
Q-Codes
Also known as: trastuzumab biosimilar, Hercessi, HER2-positive therapy
Injection of trastuzumab-hercessi (Hercessi), a biosimilar to trastuzumab, administered at 10 milligrams per dose.
Clinical Context
Used for HER2-positive breast cancer and gastric cancer. Administered intravenously as part of multimodal oncologic therapy. Binds to human epidermal growth factor receptor 2.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.